Skip to main content

Gyre Therapeutics, Inc.

GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001124105

No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Gyre Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
66
−1 vs. Q2 2021
Shares held
18.4M
−1.70M (−8.5%) vs. Q2 2021
Total value
$75.7M
−$11.3M (−13.0%) vs. Q2 2021
New holders
15
9 more added
Sold out
16
31 more reduced

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 66 institutions
Q1 2021: 89 institutionsQ2 2021: 69 institutionsQ3 2021: 66 institutionsQ4 2021: 51 institutionsQ1 2022: 43 institutionsQ2 2022: 41 institutionsQ3 2022: 35 institutionsQ4 2022: 35 institutionsQ1 2023: 40 institutionsQ2 2023: 29 institutionsQ3 2023: 32 institutionsQ4 2023: 16 institutionsQ1 2024: 21 institutionsQ2 2024: 30 institutionsQ3 2024: 37 institutionsQ4 2024: 41 institutionsQ1 2025: 46 institutionsQ2 2025: 48 institutionsQ3 2025: 48 institutionsQ4 2025: 44 institutionsQ1 2026: 56 institutionsQ2 2026: 59 institutions
Value heldQ3 2021: $75.7M
Q1 2021: $113.0MQ2 2021: $87.7MQ3 2021: $75.7MQ4 2021: $13.7MQ1 2022: $6.39MQ2 2022: $14.2MQ3 2022: $3.90MQ4 2022: $2.63MQ1 2023: $707.6KQ2 2023: $796.3KQ3 2023: $1.04MQ4 2023: $15.6MQ1 2024: $14.3MQ2 2024: $15.0MQ3 2024: $20.2MQ4 2024: $21.6MQ1 2025: $20.1MQ2 2025: $25.1MQ3 2025: $23.1MQ4 2025: $23.6MQ1 2026: $23.8MQ2 2026: $57.1M
Institutions holding GYRE and their total value by quarter
QuarterHoldersValue
Q2 202659$57.1M
Q1 202656$23.8M
Q4 202544$23.6M
Q3 202548$23.1M
Q2 202548$25.1M
Q1 202546$20.1M
Q4 202441$21.6M
Q3 202437$20.2M
Q2 202430$15.0M
Q1 202421$14.3M
Q4 202316$15.6M
Q3 202332$1.04M
Q2 202329$796.3K
Q1 202340$707.6K
Q4 202235$2.63M
Q3 202235$3.90M
Q2 202241$14.2M
Q1 202243$6.39M
Q4 202151$13.7M
Q3 202166$75.7M
Q2 202169$87.7M
Q1 202189$113.0M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding GYRE in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC2,711,600$11.1M0.12%+593,000+28.0%Added
Stonepine Capital Management, LLC2,635,014$10.8M4.93%−441,362−14.3%Reduced
Nantahala Capital Management, LLC2,432,212$10.0M0.59%−99,148−3.9%Reduced
22NW, LP1,429,242$5.87M1.75%00.0%Unchanged
Vanguard Group Inc1,423,382$5.85M0.00%+1,051+0.1%Added
Ghost Tree Capital, LLC1,000,000$4.11M1.36%00.0%Unchanged
Dimensional Fund Advisors LP801,440$3.29M0.00%−124,266−13.4%Reduced
Millennium Management LLC671,224$2.76M0.00%−116,524−14.8%Reduced
Sio Capital Management, LLC623,892$2.56M0.83%00.0%Unchanged
Ikarian Capital, LLC454,346$1.87M0.43%−126,854−21.8%Reduced
Pura Vida Investments, LLC372,582$1.53M0.12%+372,582New
Acuta Capital Partners, LLC365,000$1.50M0.53%−320,000−46.7%Reduced
Geode Capital Management, LLC351,541$1.44M0.00%+19,062+5.7%Added
BlackRock Inc.270,718$1.11M0.00%−12,105−4.3%Reduced
Bank of Montreal201,265$962.0K0.00%−11,133−5.2%Reduced
Gsa Capital Partners LLP175,751$722.0K0.07%+6,216+3.7%Added
Goldman Sachs Group Inc160,701$660.0K0.00%−100,286−38.4%Reduced
Parkman Healthcare Partners LLC133,449$548.0K0.14%−260,000−66.1%Reduced
RBF Capital, LLC132,396$544.0K0.03%−25,795−16.3%Reduced
Raymond James & Associates129,553$532.0K0.00%−5,576−4.1%Reduced
AlphaCentric Advisors LLC114,000$469.0K0.12%−68,500−37.5%Reduced
Two Sigma Advisers, LP107,000$440.0K0.00%−45,900−30.0%Reduced
Sabby Management, LLC105,742$435.0K0.10%+105,742New
Ergoteles LLC105,211$432.0K0.02%−3,289−3.0%Reduced
Northern Trust Corp103,370$425.0K0.00%−3,573−3.3%Reduced
Schonfeld Strategic Advisors LLC89,400$367.0K0.00%−5,400−5.7%Reduced
Essex Woodlands Management, Inc.78,622$323.0K0.07%00.0%Unchanged
Morgan Stanley78,080$321.0K0.00%−28,029−26.4%Reduced
Bank of New York Mellon Corp75,309$309.0K0.00%00.0%Unchanged
State Street Corp72,599$298.0K0.00%+29,200+67.3%Added
Johnson & Johnson66,951$275.0K0.02%+66,951New
Citadel Advisors LLC65,409$268.0K0.00%+65,409New
J. Goldman & Co LP60,755$250.0K0.02%+60,755New
Davenport & Co LLC59,400$244.0K0.00%−10,000−14.4%Reduced
Two Sigma Investments, LP54,069$222.0K0.00%+15,813+41.3%Added
HRT Financial LP53,788$221.0K0.00%−36,012−40.1%Reduced
Tocqueville Asset Management L.P.50,080$206.0K0.00%−4,500−8.2%Reduced
Raymond James Financial Services Advisors, Inc.49,812$205.0K0.00%−225−0.4%Reduced
Boothbay Fund Management, LLC45,915$189.0K0.01%−20,510−30.9%Reduced
Black Diamond Financial, LLC42,000$173.0K0.08%00.0%Unchanged
Walleye Capital LLC40,520$167.0K0.01%+40,520New
Renaissance Technologies LLC39,785$164.0K0.00%−408,412−91.1%Reduced
Barclays PLC33,850$139.0K0.00%+218+0.6%Added
CSS LLC33,549$138.0K0.01%+33,549New
HSBC Holdings PLC32,528$134.0K0.00%00.0%Unchanged
JPMorgan Chase & Co31,107$128.0K0.00%−53,889−63.4%Reduced
Virtu Financial LLC29,103$120.0K0.01%+29,103New
Bank of America Corp25,959$107.0K0.00%−5,042−16.3%Reduced
Squarepoint Ops LLC25,527$105.0K0.00%−21,533−45.8%Reduced
PDT Partners, LLC21,563$89.0K0.01%+9,769+82.8%Added
Cherry Creek Investment Advisors, Inc.20,000$82.0K0.05%+20,000New
Stephens Inc16,835$69.0K0.00%−50−0.3%Reduced
Kalos Management, Inc.16,710$58.0K0.02%−700−4.0%Reduced
Colorado Capital Management, Inc.13,712$56.0K0.04%00.0%Unchanged
Walleye Trading LLC13,507$56.0K0.00%+13,507New
Commonwealth Equity Services, LLC10,000$41.0K0.00%+10,000New
Silverarc Capital Management, LLC10,000$41.0K0.02%+10,000New
Steward Partners Investment Advisory, LLC8,000$33.0K0.00%−2,000−20.0%Reduced
Cutler Group LP5,500$22.0K0.00%00.0%Unchanged
Total Clarity Wealth Management, Inc.2,000$8.00K0.00%+2,000New
Capital Advisory Group Advisory Services, LLC1,000$4.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA537$2.21K0.00%+44+8.9%Added
Wells Fargo & Company479$2.00K0.00%−23−4.6%Reduced
Jacobi Capital Management LLC200$1.00K0.00%00.0%Unchanged
American Portfolios Advisors215$8840.00%+215New
FMR LLC1$00.00%+1New
Verition Fund Management LLC0$00.00%−387,101−100.0%Sold out
Deutsche Bank AG0$00.00%−194,933−100.0%Sold out
Tibra Equities Europe Ltd0$00.00%−79,200−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−55,219−100.0%Sold out
Trexquant Investment LP0$00.00%−32,220−100.0%Sold out
Parametric Portfolio Associates LLC0$00.00%−21,019−100.0%Sold out
Advisory Services Network, LLC0$00.00%−19,700−100.0%Sold out
Quantitative Systematic Strategies LLC0$00.00%−16,277−100.0%Sold out
XTX Topco Ltd0$00.00%−15,265−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−13,113−100.0%Sold out
Group One Trading, L.P.0$00.00%−6,508−100.0%Sold out
UBS Group AG0$00.00%−2,609−100.0%Sold out
Royal Bank of Canada0$00.00%−2,174−100.0%Sold out
Federation des caisses Desjardins du Quebec0$00.00%−1,125−100.0%Sold out
New York State Common Retirement Fund0$00.00%−257−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−336−100.0%Sold out
M Holdings Securities, Inc.––––Not filed
Johnson & Johnson Innovation - JJDC, Inc.––––Not filed